1
|
Camgrand E, Christine BC, Harroch E, Chouquet C, Barthelemy C, Ory-Magne F, Leung C, Barbosa RP, Rascol O, Fabbri M. Discontinuation rate and long-term adverse events path of apomorphine infusion in advanced Parkinson's disease patients. Parkinsonism Relat Disord 2023; 116:105859. [PMID: 37788512 DOI: 10.1016/j.parkreldis.2023.105859] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/23/2023] [Revised: 08/31/2023] [Accepted: 09/15/2023] [Indexed: 10/05/2023]
Affiliation(s)
- Eva Camgrand
- Parkinson's Disease Expert Centre, Toulouse University Hospital, France
| | | | - Estelle Harroch
- Parkinson's Disease Expert Centre, Toulouse University Hospital, France
| | - Cécile Chouquet
- University of Toulouse, Mathematics Departement, Toulouse, France
| | | | | | - Clémence Leung
- Parkinson's Disease Expert Centre, Toulouse University Hospital, France; French Reference Center for Multiple System Atrophy, Neurology Department, Toulouse University Hospital and Institute of Metabolic and Cardiovascular Diseases INSERM UMR 1297, Toulouse, France
| | | | - Olivier Rascol
- French Reference Center for Multiple System Atrophy, Neurology Department, Toulouse University Hospital and Institute of Metabolic and Cardiovascular Diseases INSERM UMR 1297, Toulouse, France; Clinical Investigation Center CIC1436, Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre and NeuroToul Center of Excellence in Neurodegeneration (COEN) of Toulouse; INSERM, University of Toulouse 3, CHU of Toulouse, Toulouse, France
| | - Margherita Fabbri
- French Reference Center for Multiple System Atrophy, Neurology Department, Toulouse University Hospital and Institute of Metabolic and Cardiovascular Diseases INSERM UMR 1297, Toulouse, France; Clinical Investigation Center CIC1436, Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Centre and NeuroToul Center of Excellence in Neurodegeneration (COEN) of Toulouse; INSERM, University of Toulouse 3, CHU of Toulouse, Toulouse, France.
| |
Collapse
|